==== Front Infect Drug ResistInfect Drug ResistInfection and Drug ResistanceInfection and Drug Resistance1178-6973Dove Medical Press 10.2147/IDR.S161075idr-11-1031Original ResearchHigh prevalence of hypervirulent Klebsiella pneumoniae infection in the genetic background of elderly patients in two teaching hospitals in China Liu Chao 1Shi Jiaojiao 2Guo Jun 34 1 Department of Respiratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, China-Japan Friendship Hospital, Beijing, China 2 Department of Respiratory Medicine, Peking University Third Hospital, Peking University, Beijing, China 3 Department of Respiratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China, guojunhx301@163.com 4 Department of Geriatric Respiratory Medicine, Chinese PLA General Hospital, Beijing, China, guojunhx301@163.comCorrespondence: Jun Guo, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No. 168, Litang Road, Changping District, Beijing 102218, China, Tel +86 1 368 157 3493, Email guojunhx301@163.com2018 31 7 2018 11 1031 1041 © 2018 Liu et al. This work is published and licensed by Dove Medical Press Limited2018The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.Purpose Aerobactin is a critical factor for hypervirulent Klebsiella pneumoniae (hvKp) in genetic backgrounds, but data based on the genotype for the elderly is limited. Materials and methods A retrospective study was conducted on elderly patients from June 2008 to July 2017 in 2 teaching hospitals. The clinical and microbiological data, including antimicrobial susceptibility testing, string test, extended-spectrum β-lactamase (ESBL) production, virulence gene, and multilocus sequence typing, of the hvKp group defined as aerobactin positive were compared with those of classic K. pneumoniae isolates. Results A total of 45.7% of 202 K. pneumoniae isolates were hvKp.ST23, which were predominant in 2 hospitals, but they were not highly associated with hvKp in different hospitals. Hypermucoviscosity, K1, K2, magA, and rmpA/A2 genes were highly related to hvKp (P=0.000). With regard to the host, invasive infections (P=0.000), liver abscess (P=0.000), abdominal infection (P=0.000), pneumonia (P=0.037), and septic shock (P=0.045) were significantly higher in the elderly with hvKp. In the hvKp group, patients with better nutritional status were associated with a more severe sequential organ failure assessment score and a more serious inflammation reaction. Patients with diabetes (odds ratio [OR]=2.566) are more likely to be infected with hvKp. Previous hvKp is associated with hypermucoviscosity (OR=15.249) are often paralleled with hvKp. Importantly, 26% of hvKp isolates produced ESBLs, and most of them showed a carbapenems-resistant (CR) phenotype. Multivariate analysis implied that patients with a history of surgery within the last 1 month (OR=15.999) is an independent risk factor for CR-hvKp infection. Conclusion The prevalence of hvKP is high in the elderly. ESBL-hvKp, especially CR-hvKp, is emerging, which is a sign that clinical awareness and infection monitoring needs to improve. Keywords Klebsiella pneumoniaehypervirulentaerobactinrisk factorESBL-hvKpCR-hvKp ==== Body Introduction Klebsiella pneumoniae is a Gram-negative bacterium, causing various fatal infections. There are 2 pathotypes: hypervirulent (hvKp) and classical (cKp), which are detrimental to our health. Initially, a string test with a length >5 mm was defined as hypermucoviscosity, which is a traditional unique hvKp trait, triggering aggressive invasive infection, such as bloodstream infection and pyogenic liver abscesses (PLAs) for immunocompetent ambulatory younger individuals with non-underlying diseases.1–4 However, many studies do not agree with the definition of hvKp defined by hypermucoviscosity phenotype.5,6 The reason is that few hypermucoviscous K. pneumoniae (hmvKp) strains are associated with high virulence with in vitro and in vivo assays.5,6 Thus, using hvKp by hypermucoviscosity phenotype as the sole indicator of hvKp is not appropriate.7,8 Until recently, aerobactin, the dominant siderophore, was regarded as a critical virulence factor for hvKp genetic background.1,8,9 A multicenter study, focusing on middle-aged patients, first demonstrated the clinical and molecular characteristic of hvKp (defined as aerobactin positive) infection.8 But data are limited on the elderly who may have various underlying diseases, nutrition status, and atypical manifestations, along with being infected with genotype hvKp. Many previous studies have illustrated that hvKp is sensitive to most antibiotics, which is not frequently present in infection with cKp strains. But emerging multidrug resistance (MDR) hvKp, especially resistant to colistin and carbapenems, has been reported in China.10–12 However, there are not enough adapted data on the elderly and the characteristics of antimicrobial-resistant hvKp infection. Thus, for further investigation of the prevalence and antibiotic resistance of hvKp, we conducted a retrospective study in 2 teaching hospitals based on the genotype of hvKp, which was defined as aerobactin positive. Materials and methods Patients A retrospective study was conducted on 202 K. pneumoniae culture-positive patients diagnosed at Beijing Tsinghua Changgung Hospital and Chinese PLA General Hospital from June 2008 to July 2017. The definition of elderly was if the patient was ≥65 years. Duplicate isolates from the same patient were excluded. The clinical characteristics, including underlying disease, infection type, nutritional status, mortality in 30 days, and sequential organ failure assessment (SOFA), were collected. To recognize the host responsibility and nutritional status between the 2 pathotypes, white blood cell count (WBC) and neutrophil percentage (NEU%) were used as primary and rough inflammatory factors. To evaluate the nutrition status, we used total protein (TP) and albumin (ALB) as markers. The study was approved by the Chinese PLA General Hospital Ethics Committee, and the Guidelines for Human Experimentation (China) were followed through the whole study. Informed consent was not needed due to the retrospective nature of the study; additionally, the patient data accessed in this research was anonymous. Therefore, the Chinese PLA General Hospital Ethics Committee waived the need for consent. K. pneumoniae strains All isolates were stored at −80°C and previously identified by the API 20 NE system and the Vitek II system. Additionally, species identification was further confirmed by 16S rRNA gene sequencing. HvKp was defined as aerobactin positive. Hypermucoviscous phenotype was confirmed by string test as described previously.13 Antimicrobial susceptibility testing and phenotypic detection of ESBLs Antimicrobial susceptibility testing was conducted and the results were interpreted by 2017 Clinical and Laboratory Standards Institute (CLSI) guidelines. The antibiotics include amikacin, gentamicin, tobramycin, ampicillin/sulbactam, aztreonam, cefazolin, cefepime, ceftriaxone, ceftazidime, ciprofloxacin, levofloxacin, piperacillin/tazobactam, and trimethoprim/sulfamethoxazole. ESBL was confirmed by agar dilution test using ceftazidime and cefotaxime combined with clavulanate according to the CLSI guidelines.8 MDR strains were defined as resistant to ≥3 different antimicrobial categories.14 Isolates that are resistant to both imipenem and meropenem are defined as carbapenems-resistant (CR) isolates. Detection of virulence gene Genomic DNA of all K. pneumoniae isolates was extracted. Virulence-associated genes (rmpA, rmpA2, magA, and aerobactin) and capsular serotype-specific (cps) genes (K1, K2, K5, K20, K54, and K57) were amplified by polymerase chain reaction (PCR).8,15–17 The primers are listed in Table S1. Multilocus sequence typing (MLST) for K. pneumoniae Seven housekeeping genes (gapA, mdh, phoE, tonB, infB, pgi, and rpoB) were amplified by PCR following the protocol (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html) (Table S1). Allelic profiling and sequence types (STs) determination were also confirmed on the aforementioned website. Moreover, to further analyze the relationship among different STs, phylogenetic analysis of spliced 7 housekeeping genes for frequency >1 isolates and strains contributing to invasive infection and mortality was performed by the neighbor-joining method (MEGA 7.0). Statistical analysis SPSS software (version 20.0; IBM Corporation, Armonk, NY, USA) was performed for data analysis. Measurement data were assessed as mean ± SD. The count data was analyzed as percentages. Continuous variables were analyzed by Student’s t-tests and the Wilcoxon rank-sum tests. Categorical variables were analyzed by χ2 or Fisher’s exact test. Univariate logistic regression analyses were performed for risk factor. To further analyze independent risk factors, a multivariable logistic regression analysis was conducted. All variables with P values of <0.05 were included in the multivariate model. All tests were 2-tailed. P-value <0.05 was considered significant. Results Patient characteristics A total of 202 K. pneumoniae culture-positive patients were diagnosed at the 2 hospitals from June 2008 to July 2017. A total of 96 (47.5%) isolates were hvKp and 121 (59.9%) were hmvKp. All the PLA patients (10 cases) were infected with hvKp. The main infection type distribution in hospital was pneumonia (146, 72.3%), while other infection types included urinary infection (42, 20.8%), invasive infection (37, 18.3%), and abdominal infection (26, 12.9%). Moreover, almost half of the patients (98, 48.5%) presented with sepsis, and 24 (11.9%) were diagnosed as septic shock. A total of 181 (89.6%) were males and 21 (10.4%) were females; the mean age was 84.43±7.84 years. Clinical features: hvKp vs. cKp Clinical features are shown in Table 1. The mean age of the hvKp group was younger than the cKp group (83.24±7.35 vs. 85.5±8.14 years, P=0.039). Diabetes (72.9% vs. 48.1%; P=0.000) and digestive diseases (22.9% vs. 13.5%; P=0.046) were highly associated with the hvKp group as their underlying diseases. Compared with the cKp group, a significantly higher number of patients with the hvKp presented with invasive infections (30.2% vs. 7.5%; P=0.000), liver abscess (10.4% vs. 0%; P=0.000), other abscess (26.0% vs. 2.8%; P=0.035), septic shock (16.7% vs. 7.5%; P=0.045), pneumonia (79.2% vs. 66.0%; P=0.037), and abdominal infection (21.9% vs. 4.7%; P=0.000). However, the incidence rates of urinary infection (13.5% vs. 27.4%, P=0.016) and stomach tube indwelling (60.4% vs. 77.4%, P=0.009) were comparably lower in the hvKp group. WBC (12.74±3.94 109/L vs. 10.59±3.48 109/L, P=0.000) and NEU% (78.70±8.02 vs. 75.60±8.50, P=0.003) of patients with hvKp, represented as host responsibility, were significantly higher than cKp group. However, patients infected with hvKp were more likely to have a poorer nutritional status in TP (64.74±5.42 vs. 62.83±6.32, P=0.023) and ALB (34.98±3.40 vs. 33.78±3.73, P=0.019). Moreover, although the mortality in 30 days (16.7% vs. 21.7%, P=0.366) was not significantly different, SOFA score in patients with hvKp was notably higher (6.79±2.88 vs. 4.93±2.59, P=0.000; Table 1). Genetic and phenotype characteristics: hvKp vs. cKp Previous studies confirmed that virulence-associated genes (rmpA, rmpA2, and magA) and cps genes (K1, K2, K5, K20, K54, and K57) are clustered in the hvKp group.18–20 A significant difference was that K1, K2, rmpA, rmpA2, and magA were highly clustered in hvKp (P=0.000, respectively), and K5, K20, K54, and K57 were not associated with hvKp (P=0.106, 0.627, 0.894, and 0.211, respectively). There was no strain in the cKp group with K5 (Table 1). It was strongly noted that hypermucoviscosity was highly associated with hvKp (P=0.000). Antimicrobial resistance and prevalence of ESBL-producing K. pneumoniae isolates Most of the hvKp isolates were sensitive to most of the antibiotics, with the exception of ampicillin, imipenem, and meropenem (Table 2). All Kp strains were resistant to ampicillin. In the hvKp group, 24 strains (25.0%) were MDR. A total of 25 hvKp isolates were identified as ESBL-producing K. pneumoniae isolates, which were more common in the cKp group (53.8% vs. 26.0%, P=0.001). One CR-hvKp isolate existed in one of these 2 teaching hospitals. In another referral center, 10 CR-hvKp strains were detected. The detailed information for the 11 CR-hvKp strains is shown in Table S2. Risk factors: hvKp vs. cKp In this study, univariate regression analysis showed that diabetes (odds ratio [OR]=2.903), digestive diseases (OR=2.127), and hypermucoviscosity (OR=17.446) were notable risk factors for hvKp infection. However, indwelling stomach tube (OR=0.447) was a protective factor for hvKp infection. Moreover, multivariate analysis revealed that diabetes (OR=2.566) and hypermucoviscosity (OR=15.249) were independent risk factors for hvKp infections (Table 3). Risk factors: CR-hvKp vs. non-CR-hvKp Patients with surgery history within 1 month (OR=19.5) and catheterized tracheal catheter (OR=6.051) were closely associated with CR-hvKp. However, patients with diabetes (OR=0.256) were more likely to be infected with non-CR-hvKp. A history of surgery within the last 1 month is an independent risk factor for CR-hvKp infection (OR=15.999) (Table 4). MLST genotypic analysis Among the 202 K. pneumoniae isolates, no new ST was identified in MLST database. The most prevalent ST in this study was ST23 (n=28; 13.9%), followed by ST412 (n=10; 5.0%), ST37 (n=7; 3.5%), ST65 (n=6; 3.0%), ST11 (n=5; 2.5%), ST17 (n=5; 2.5%), ST2905 (n=5; 2.5%), and ST2906 (n=5; 2.5%). The aforementioned STs accounted for 35.1% (43/202) of the total strains. Among the primary STs, ST23 (24/28), ST412 (6/9), ST17(5/5), and ST65(3/6) were strongly associated with hvKp, while ST11(0/5), ST2905(1/5), ST2906(1/5), and ST37(2/7) were more common in the cKp group. The more common clone complexes (CCs) of the CR-hvKp group were CC23 (n=3) and CC17 (n=3). There is an important phenomenon in the phylogenetic tree that a branch clustered with ST347, ST595, ST1469, ST2905, and ST2906 contributed to poor prognosis death in 30 days, which should be paid more attention (Figure 1). Discussion To our knowledge, this is the first and biggest systematic study focusing on the elderly infected with hvKp in China. In this study, 59.9% of hvKp were identified as hypermucoviscous by string test, which was significantly different from a previous retrospective study conducted in a single center in China, with a prevalence of 33% in Beijing.13 In addition, the incidence of hvKp (47.5%) in genetic background is also higher than the figure in the previous multicenter studies (37.8%).8 It can be concluded that hvKp is emerging as the major pathotype for the elderly in the 2 hospitals, which should be paid more attention. The prevalent ST in 2 hospitals is the same: ST23. However, different hospitals isolated with ST23 are not highly associated with hvKp, which indicates that fully relying on STs to identify hvKp may be unreliable. Although the definition of hvKp is controversial, it is an objective marker, like plasmid type, biofilm producing, serotypes and the ability of trigger inflammatory factors that may be needed for further study to complement the real hypervirulence. Therefore, the prevalence of hvKp may be incorrectly estimated due to the lack of definite and objective diagnostic methods. HvKp causes various severe infections, posing a serious threat to health. Various types of K-antigen have been reported,17,21,22 with the more important elements in Asia being K1 and K2, which are the reason for severe infection. But they are not the unique trait for hvKp.23,24 MagA is not a specific virulence gene for hvKp isolates causing PLA,25 but it is highly associated with cps K1.22,26 Moreover, the mutant isolate (knockout magA) could not show hmv phenotype.27 RmpA/RmpA2 was proposed as a virulent factor in addition to magA and cps K1/K2.16 Although rmpA is not an independent factor contributing to pyogenic liver abscess, it promotes capsule synthesis, which is associated with hypermucoviscous.3,16 Our results are consistent with a previous study: invasive infection (especially liver abscess), hypermucoviscosity, and mainly virulence factors (K1, K2, rmpA, and magA genes) are highly presented in hvKp group.8 So, a better understanding of risk factors is essential to make interventions. Our results show that patients with diabetes are more likely to be infected with hvKp. Additionally, hypermucoviscosity is strongly associated with hvKp. In our study, patients with surgery history of <1 month are an independent risk factor for CR-hvKp infection, which should be focused more on how to prevent infection. A previous study concluded that major histocompatibility complex variants, nutritional status, and gut microbiota are essential host factors to improve the understanding of the hypervirulence phenomenon.7 Our results demonstrated that in the hvKp group, patients with better nutritional status are associated with a more severe SOFA score and more serious inflammation reaction. All aforementioned characteristics may be a potential marker for early and precise empirical interventions for the elderly with hvKp. Previous studies have revealed that most hvKp and antimicrobial-resistant patterns were non-overlapping.8,13 In this study, most hvKp were sensitive to most of the aforementioned antibiotics. In the hvKp group, the number of MDR-hvKp (25.0%) and ESBL-hvKp (26.0%) is significantly higher compared to the previous study performed in the multicenter study, with a prevalence of 12.6%.8 It is alarming that the number of elderly with MDR-hvKp infection is increasing. Moreover, 1 CR-hvKp isolate was detected in 1 hospital, where long-term patients were hospitalized. However, 10 CR-hvKp strains were detected in the other hospital, which was a referral center receiving patients from other hospitals and the community. Therefore, the incidence of CR-hvKp may be underestimated in this region. Thus, these data revealed that MDR-hvKp is emerging among the elderly. However, to confirm this conclusion, further investigation using a larger population is needed. The CR-hvKp was not detected in nosocomial environment by routine nosocomial infection surveillance. In addition, the 2 hospitals did not apply the use of anal swab for monitoring nosocomial infection. It is unclear whether gut microbiota composed of hvKp contributed to the infection. Thus, it is essential to enhance hospital infection surveillance for the elderly. A previous study suggested that wards previously infected with CR-hvKp should be disinfected and left unoccupied for >2 weeks.10 Otherwise it may be a good site for a fatal outbreak of the organism. There are some limitations in our study. First, it was a retrospective study in 2 teaching hospitals for over 10 years. Most key inflammatory and nutrition status marker were not achieved. Second, in vitro and in vivo experiments as objective evidence, such as Galleria mellonella, mouse, or human neutrophil assay, may be needed to identify the real virulent Kp. Third, to further explore the pathogen genomic characteristics, especially for virulent and antibiotic-resistant environment, whole genome sequencing, transcriptomics, and proteomics may be needed. A larger prospective multicenter study, focusing on host, pathogen, and host–pathogen interaction (inflammatory factor), is needed to better defining the hvKp strains. Conclusion The prevalence of hvKp may be higher than expected in the elderly. The epidemiology for hvKp in different hospitals is different. Although the definition of hvKp is still controversial, hvKp (aerobactin positive) strains were more likely to cause serious infections, such as liver abscess and septic shock, and more severe inflammatory reaction in the host. To further understand hvKp, host, pathogen, and host–pathogen interaction may be taken into consideration. The emerging MDR-hvKp, especially CR-hvKp, will be a great challenge for treatment. It is essential to enhance clinical awareness and management for the different types of hvKp infections. Supplementary materials Table S1 Primers Name Sequence rmpA  Forward 5-ACTGGGCTACCTCTGCTTCA-3  Reverse 5-CTTGCATGAGCCATCTTTCA-3 rmpA2  Forward 5-CTTTATGTGCAATAAG-GATGTT-3  Reverse 5-CCTCCTGGAGAGTAAGCATT-3 magA  Forward 5-GGTGCTCTTTACATCATTGC-3  Reverse 5-GCAATGGCCATTTGCGTTAG-3 aerobactin  Forward 5-GCATAGGCGGATACGAACAT-3  Reverse 5-CACAGGGCAATTGCTTACCT-3 K1  Forward 5-GTAGGTATTGCAAGCCATGC-3  Reverse 5-GCCCAGGTTAATGAATCCGT-3 K2  Forward 5-GGAGCCATTTGAATTCGGTG-3  Reverse 5-TCCCTAGCACTGGCTTAAGT-3 K5  Forward 5-GCCACCTCTAAGCATATAGC-3  Reverse 5-CGCACCAGTAATTCCAACAG-3 K20  Forward 5-CCGATTCGGTCAACTAGCTT-3  Reverse 5-GCACCTCTATGAACTTTCAG-3 K54  Forward 5-CATTAGCTCAGTGGTTGGCT-3  Reverse 5-GCTTGACAAACACCATAGCAG-3 K57  Forward 5-CGACAAATCTCTCCTGACGA-3  Reverse 5-CGCGACAAACATAACACTCG-3 rpoB  Forward 5-GGCGAAATGGCWGAGAACCA-3  Reverse 5-GAGTCTTCGAAGTTGTAACC-3 gapA  Forward 5-TGAAATATGACTCCACTCACGG-3  Reverse 5-CTTCAGAAGCGGCTTTGATGGCTT-3 mdh  Forward 5-TGAAATATGACTCCACTCACGG-3  Reverse 5-CTTCAGAAGCGGCTTTGATGGCTT-3 pgi  Forward 5-GAGAAAAACCTGCCTGTACTGCTGGC-3  Reverse 5-CGCGCCACGCTTTATAGCGGTTAAT-3 phoE  Forward 5-ACCTACCGCAACACCGACTTCTTCGG-3  Reverse 5-TGATCAGAACTGGTAGGTGAT-3 infB  Forward 5-CTCGCTGCTGGACTATATTCG-3  Reverse 5-CGCTTTCAGCTCAAGAACTTC-3 tonB  Forward 5-CTTTATACCTCGGTACATCAGGTT-3  Reverse 5-ATTCGCCGGCTGRGCRGAGAG-3 Table S2 Detailed clinical and microbiological features of CR-hvKp strains Clinical features P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 Age (years) 87 87 87 88 79 71 65 65 77 84 94 Gender F M M F M F F M M M M Clinical department Internal medicine Emergency General surgery ICU General surgery ICU ICU Thoracic surgery ICU Thoracic surgery Respiratory Main underlying diseases Bone fracture; Cardiovascular diseases Diabetes Surgery with in 1 month Cerebrovascular disease Cancer; Surgery with in 1 month Cancer; Surgery with in 1 month Diabetes; Cerebrovascular disease Cancer Cancer; Surgery with in 1 month Surgery with in 1 month Cancer; Cerebrovascular disease; diabetes Tube CVC; Ureter Ureter; Stomach tube None CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter CVC; Ureter; Stomach tube; Tracheal catheter Specimen type Sputum Sputum Pyogenic fluids Bile Sputum +Blood +Wound Bile+Blood Sputum+Urine +Feces Sputum Pyogenic fluids Sputum+Urine Drainage liquid Infection type Pneumonia Pneumonia Abscess PLA Sepsis Septic shock Septic shock Sepsis Septic shock Septic shock Sepsis WBC(109/L) 12.21 10.85 13.76 16.44 8.80 15.49 10.0 18.32 11.66 9.51 4.64 NEU (%) 75.1 86.6 92.5 82.2 56.8 83.4 69.9 87.4 88.0 65.2 68.3 TP (g/L) 79.4 60.5 69.4 52.8 54.7 49.6 59 70.9 62 67.4 61.2 ALB (g/L) 40.3 27.7 34.6 28.2 20.6 30.0 32.6 36.4 27.4 31.7 35.0 Sensitive antibiotics N N N N GEN; LEV; TOB N SMZ; TOB; AMK SMZ N N SMZ; AMK SOFA score 6 10 2 13 7 9 7 4 5 6 7 Empiric therapy CIP+CAZ CIP+CAZ IPM IPM+ISE IPM+MXF CIP+CAZ IPM+ISE IPM IPM MXF MEM Switched therapy MEM+TGC MEM+TGC TGC TGC GEN+LEV TGC+MEM TGC+MEM+FOS TGC+MEM TGC+MEM TGC+MEM+FOS TGC Clinical outcome Survived Survived Survived Survived Survived Survived Survived Died Survived Survived Survived String test + + + + + + + − − + + Virulence-associated genes  rmpA + + + + + + + − − + +  rmpA2 + + + + + + + − − + +  magA + + + + + + + − + + + cps genes  K1 + − − + + + + − − + −  K2 + + + + + + + − − + −  K5 − − − − − − − + + − −  K20 − + − − + − − − + − −  K54 − − − − − − + − − − −  K57 + − − − − + − − − − − MLST genotyping 23 23 17 17 347 17 2905 2906 23 412 2874 Abbreviations: ALB, albumin; AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CMZ, cefmetazole; CVC, central venous catheter; F, female; FOS, fosfomycin; GEN, gentamicin; ICU, intensive care unit; IPM, imipenem; ISE, isepamicin; LEV, levofloxacin; MLST, multilocus sequence typing; M, male; MEM, meropenem; Mo, month; MXF, moxifloxacin; NEU, neutrophils; N, no; PLA; pyogenic liver abscess; SMZ, sulfamethoxazole; SOFA, sequential organ failure assessment; TGC, tigecycline; TOB, tobramycin; TP, total protein; TZP, piperacillin tazobactam; WBC, white blood cell; Y, yes; +, positive; −, negative. Acknowledgments We thank the team of curators of the Institut Pasteur MLST and whole genome MLST databases for curating the data and making them publicly available at http://bigsdb.pasteur.fr. Additionally, we thank Huicheng Wang for statistics, who works in China Food and Drug Administration. This work was supported by the China Postdoctoral Science Foundation (grant number 2014M562610) and the Excellent Young Program of the Organization Department of Beijing Municipal Party Committee (grant number 2016000057592G258). Disclosure The authors report no conflicts of interest in this work. Figure 1 Neighbor-joining dendrogram showing concatenated sequences of 7 housekeeping genes from the MLST database for the frequency >1 STs and isolates contributing to invasive infection and mortality. Yellow solid rim represents death. Abbreviations: MLST, multilocus sequence typing; ST, sequence type. Table 1 Clinical and microbiological features of hvKp Characteristic hvKp (N=96) cKp (N=106) P-value K serotype  K1 33 (34.4%) 2 (1.9%) 0.000  K2 20 (20.8%) 2 (1.9%) 0.000  K5 3 (3.1%) 0 (0%) 0.106  K20 6 (6.3%) 4 (3.8%) 0.627  K54 4 (3.8%) 3 (2.8%) 0.894  K57 10 (10.4%) 6 (6.3%) 0.211 rmpA 76 (79.2%) 12 (11.3%) 0.000 rmpA2 68 (70.8%) 15 (14.2%) 0.000 magA 77 (80.2%) 50 (47.2%) 0.000 Hypermucoviscosity 86 (89.6%) 35 (33.0%) 0.000 Basic demographics Age 83.24±7.35 85.5±8.14 0.039 Male 93 (96.9%) 88 (83.0%) 0.361 Underlying diseases Pulmonary disease 86 (89.6%) 85 (80.2%) 0.064 Diabetes 70 (72.9%) 51 (48.1%) 0.000 Cardiovascular disease 45 (46.9%) 60 (56.6%) 0.167 Cerebrovascular disease 15 (15.6%) 27 (25.5%) 0.085 Cancer 28 (29.2%) 27 (25.5%) 0.556 Surgery within 1 month 14 (14.6%) 11 (10.4%) 0.365 Digestive disease 22 (22.9%) 13 (13.5%) 0.046 Catheter Central intravenous catheter 65 (67.7%) 66 (62.3%) 0. 418 Urinary catheter 73 (76.0%) 87 (82.1%) 0.291 Tracheal catheter 34 (35.4%) 39 (36.8%) 0.839 Stomach tube 58 (60.4%) 82 (77.4%) 0.009 Infection type Pneumonia 76 (79.2%) 70 (66.0%) 0.037 Urinary infection 13 (13.5%) 29 (27.4%) 0.016 Invasive infection 29 (30.2%) 8 (7.5%) 0.000  Bacteremia 8 (8.3%) 4 (3.8%) 0.171  Liver abscess 10 (10.4%) 0 (0%) 0.000  Other abscess 25 (26.0%) 3 (2.8%) 0.000 Abdominal infection 21 (21.9%) 5 (4.7%) 0.000 Sepsis 48 (50.0%) 50 (47.2%) 0.688 Septic shock 16 (16.7%) 8 (7.5%) 0.045 Host responsibility WBC (109/L) 12.74±3.94 10.59±3.48 0.000 NEU% 78.70±8.02 75.6±8.50 0.003 Nutrition status TP 64.74±5.42 62.83±6.32 0.023 ALB 34.98±3.40 33.78±3.73 0.019 SOFA score 6.79±2.88 4.91±2.61 0.000 Infection occurred in ICU 19 (19.8%) 16 (15.1%) 0.378 Mortality in 30 days 16 (16.7%) 23 (21.7%) 0.366 Notes: Data presented as mean ± standard deviation, unless otherwise stated. Bold values indicate P<0.05. Abbreviations: ALB, albumin; cKp, classic Klebsiella pneumoniae; ESBLs, extended-spectrum β-lactamases; hvKp, hypervirulent Klebsiella pneumoniae; ICU, intensive care unit; NEU%, neutrophil percentage; SOFA, sequential organ failure assessment; TP, total protein; WBC, white blood cell count. Table 2 Antibiotic resistance: hvKp vs. cKp Antibiotic agent hvKp (N=96) cKp (N=106) P-value ESBLs 25 (16.3%) 57 (40.0%) 0.000 Amikacin 10 (2.5%) 22 (11.6%) 0.044 Gentamicin 16 (8.8%) 41 (29.5%) 0.001 Ampicillin/sulbactam 28 (20.0%) 60 (44.2%) 0.000 Aztreonam 18 (8.8%) 41 (23.2%) 0.002 Cefazolin 28 (18.8%) 59 (44.2%) 0.000 Cefotetan 14 (14.6%) 31 (29.2%) 0.012 Cefepime 15 (5.0%) 34 (14.7%) 0.006 Ceftriaxone 25 (16.3%) 51 (34.7%) 0.001 Ceftazidime 17 (7.5%) 43 (25.3%) 0.000 Ciprofloxacin 18 (10.0%) 43 (25.3%) 0.001 Levofloxacin 14 (6.3%) 40 (22.1%) 0.000 Trimethoprim/sulfamethoxazole 15 (8.8%) 44 (34.7%) 0.000 Piperacillin/tazobactam 13 (3.8%) 33 (13.7%) 0.003 Imipenem 11 (1.3%) 21 (2.1%) 0.104 Meropenem 12 (2.5%) 23 (2.1%) 0.085 Tobramycin 17 (8.8%) 39 (27.4%) 0.002 Abbreviations: cKp, classic Klebsiella pneumoniae; ESBLs, extended spectrum β-lactamase; hvKp, hypervirulent Klebsiella pneumoniae. Table 3 Risk factors for hvKp vs. cKp Variable Univariate OR (95% CI) P-value Multivariate OR (95% CI) P-value Infection occurred in ICU 1.388 (0.668–2.884) 0.380 Male 1.538 (0.608–3.888) 0.363 Hypermucoviscosity 17.446 (8.079–37.673) 0.000 15.249 (6.905–33.875) 0.000 Pulmonary diseases 2.125 (0.945–4.779) 0.068 Diabetes 2.903 (1.610–5.236) 0.000 2.566 (1.258–5.235) 0.010 Cardiovascular disease 0.676 (0.388–1.179) 0.168 Cerebrovascular disease 0.542 (0.268–1.095) 0.088 Cancer 1.205 (0.648–2.240) 0.556 Surgery within 1 month 1.475 (0.635–3.426) 0.367 Digestive diseases 2.127 (1.004–4.505) 0.046 Central intravenous catheter 1.271 (0.711–2.271) 0.419 Urinary catheter 0.693 (0.350–1.372) 0.293 Tracheal catheter 0.942 (0.530–1.673) 0.839 Stomach tube 0.447 (0.242–0.824) 0.010 Note: Bold values indicate P<0.05. Abbreviations: cKp, classic Klebsiella pneumoniae; hvKp, hypervirulent Klebsiella pneumoniae; ICU, intensive care unit; OR, odds ratio. Table 4 Risk factor for CR-hvKp vs. non-CR-hvKp Variable Univariate OR (95% CI) P-value Multivariate OR (95% CI) P-value Hypermucoviscous 0.468 (0.086–2.550) 0.380 Infection occurred in ICU 2.667 (0.692–10.277) 0.154 Pulmonary diseases 3.879 (0.052–1.112) 0.162 Cancer 2.246 (0.625–8.077) 0.215 Diabetes 0.256 (0.071–0.930) 0.038 Cardiovascular disease 0.613 (0.167–2.250) 0.461 Cerebrovascular disease 3.884 (0.965–15.313) 0.056 Surgery within 1 month 19.5 (4.567–83.265) 0.000 15.999 (3.412–75.026) 0.000 Digestive diseases 2.386 (0.662–8.602) 0.184 Central intravenous catheter 2.330 (0.472–11.501) 0.299 Tracheal catheter 6.051 (1.485–24.658) 0.012 Stomach tube 1.867 (0.462–7.535) 0.381 Urinary catheter 3.492 (0.422–28.865) 0.246 Note: Bold values indicate P<0.05. Abbreviations: cKp, classic Klebsiella pneumoniae; CR, carbapenems-resistant; hvKp, hypervirulent Klebsiella pneumoniae; ICU, intensive care unit; OR, odds ratio. ==== Refs References 1 Russo TA Olson R MacDonald U Beanan J Davidson BA Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo Infect Immun 2015 83 8 3325 3333 26056379 2 Shon AS Bajwa RP Russo TA Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed Virulence 2013 4 2 107 118 23302790 3 Siu LK Yeh KM Lin JC Fung CP Chang FY Klebsiella pneumoniae liver abscess: a new invasive syndrome Lancet Infect Dis 2012 12 11 881 887 23099082 4 Pomakova DK Hsiao CB Beanan JM Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant Eur J Clin Microbiol Infect Dis 2012 31 6 981 989 21918907 5 Zhang Y Zeng J Liu W Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China J Infect 2015 71 5 553 560 26304687 6 Lin YC Lu MC Tang HL Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain BMC Microbiol 2011 11 50 21385400 7 Catalan-Najera JC Garza-Ramos U Barrios-Camacho H Hyper-virulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes? Virulence 2017 1 13 8 Zhang Y Zhao C Wang Q High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance Antimicrob Agents Chemother 2016 60 10 6115 6120 27480857 9 Russo TA Olson R Macdonald U Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae Infect Immun 2014 82 6 2356 2367 24664504 10 Gu D Dong N Zheng Z A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study Lancet Infect Dis 2017 18 1 37 46 28864030 11 Gu DX Huang YL Ma JH Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and Escherichia coli isolates from an infant with diarrhea in China Antimicrob Agents Chemother 2016 60 8 5099 5100 27270278 12 Zhang R Lin D Chan EW Gu D Chen GX Chen S Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China Antimicrob Agents Chemother 2015 60 1 709 711 26574010 13 Li W Sun G Yu Y Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China Clin Infect Dis 2014 58 2 225 232 24099919 14 Magiorakos AP Srinivasan A Carey RB Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 2012 18 3 268 281 21793988 15 Choi MJ Ko KS Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains Antimicrob Agents Chemother 2015 59 11 6763 6773 26282408 16 Yu WL Ko WC Cheng KC Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan Clin Infect Dis 2006 42 10 1351 1358 16619144 17 Cheng NC Yu YC Tai HC Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis Clin Infect Dis 2012 55 7 930 939 22715175 18 Jung SW Chae HJ Park YJ Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea Epidemiol Infect 2013 141 2 334 340 22578630 19 Lin JC Yeh KM Chang FY The distant metastasis of pyogenic liver abscess caused by Klebsiella pneumoniae serotype K2 and the underlying disease of diabetes mellitus should be carefully interpreted Clin Infect Dis 2007 45 11 1531 1532 author reply 1532–1533 17990244 20 Lin WH Wang MC Tseng CC Clinical and microbiological characteristics of Klebsiella pneumoniae isolates causing community-acquired urinary tract infections Infection 2010 38 6 459 464 20734217 21 Pan YJ Fang HC Yang HC Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype J Clin Microbiol 2008 46 7 2231 2240 18508935 22 Chuang YP Fang CT Lai SY Chang SC Wang JT Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess J Infect Dis 2006 193 5 645 654 16453259 23 Yeh KM Kurup A Siu LK Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan J Clin Microbiol 2007 45 2 466 471 17151209 24 Brisse S Fevre C Passet V Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization PLoS One 2009 4 3 e4982 19319196 25 Yeh KM Chang FY Fung CP Lin JC Siu LK magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1 J Med Microbiol 2006 55 Pt 6 803 804 16687604 26 Struve C Bojer M Nielsen EM Hansen DS Krogfelt KA Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1 J Med Microbiol 2005 54 Pt 11 1111 1113 16192445 27 Fang CT Chuang YP Shun CT Chang SC Wang JT A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications J Exp Med 2004 199 5 697 705 14993253